Your session is about to expire
← Back to Search
High-Dose Statins for Low HDL Cholesterol
Study Summary
This trial is designed to study the effects of two commonly used statin medications on HDLc concentrations.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You drink more than 2 alcoholic drinks per day on average, which is equivalent to more than 14 drinks per week.I have a history of severe liver problems.My bad cholesterol levels are high enough to need treatment, according to national guidelines.I am under 18 years old.I am taking medication that interacts with Zocor or Lipitor.I haven't had any recent heart problems or unstable chest pain.I have a working phone number for follow-ups.I have been diagnosed with HIV/AIDS.I am allergic to or cannot take atorvastatin or simvastatin.I am 18 years old or older.
- Group 1: 2
- Group 2: 1
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 30 Other Conditions - This treatment demonstrated efficacy for 30 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the general purpose of a two-drug regimen?
"Lipidemias can be addressed with 2, and it has also proven to be effective when managing postoperative thromboembolism, anginal pain, and transient ischemic attack."
Are participants being actively sought out for this clinical investigation?
"This clinical trial is no longer taking on new patients. It was initially posted in January of 2005, with the last update occuring in July 2011. For those looking for other studies, there are 5 trials involving cholesterol and HDL levels as well as 103 investigations actively recruiting participants."
Is this research a pioneering effort?
"There is currently a wealth of activity surrounding drug 2, with 103 active trials spanning 46 countries and 348 cities. The commencement of this research dates back to 2005 when Merck Sharp & Dohme LLC sponsored an 80 patient Phase 4 trial which has since been concluded alongside 710 other studies."
Has the FDA approved the use of 2 for therapeutic purposes?
"There is ample evidence supporting the safety of this treatment, so it was assigned a score of 3 on our scale. This therapy has received approval for Phase 4 trials."
How many subjects are currently enrolled in this investigation?
"At present, this clinical trial is not searching for new participants; it was initially posted on January 1st 2005 and most recently updated July 20th 2011. Alternatively, if you seek other studies there are presently five research projects recruiting patients with cholesterol/HDL issues. Additionally, 103 trials involve active recruitment of applicants."
Share this study with friends
Copy Link
Messenger